Transmucosal Buprenorphine in the Treatment of Dyspnea: Case Series and Review of the Literature
Full ?-opioid agonists are commonly employed in advanced disease to relieve dyspnea of various etiologies. Although there are ongoing debates and studies regarding the relative efficacy of different agents, a factor limiting more general use is a concern about side effects, in particular respiratory...
Format: | Article |
---|---|
Language: | English |
Published: |
Mary Ann Liebert
2021-01-01
|
Series: | Palliative Medicine Reports |
Online Access: | https://www.liebertpub.com/doi/full/10.1089/PMR.2020.0091 |
Similar Items
-
Silica Nanoparticles in Transmucosal Drug Delivery
by: Twana Mohammed M. Ways, et al.
Published: (2020-08-01) -
RANGE AND CHARACTERISTICS TRANSMUCOSAL DOSAGE FORMS
by: N. V. Shestakov, et al.
Published: (2019-01-01) -
The application of oral transmucosal fentanyl for the treatment of breakthrough pain in cancer patients
by: D V Nevzorova, et al.
Published: (2017-06-01) -
Transmucosal Absorption Enhancers in the Drug Delivery Field
by: Sam Maher, et al.
Published: (2019-07-01) -
Transmucosal Absorption Enhancers in the Drug Delivery Field
Published: (2020)